Cite Filings / AMLX / 0001193125-26-359416
Feed Companies Filings Check
Sign in
424B5

Prospectus

Amylyx Pharmaceuticals, Inc. · Filed 2026-08-20 · Acc 0001193125-26-359416

Documents 1

  • 424B5 Prospectus , d180581d424b5.htm

Around this filing

  • 2026-08-20 4 Chief Financial Officer acquired 22,807 shares (grant or award)
  • 2026-08-20 4 Co-Chief Executive Officer acquired 60,039 shares (grant or award)
  • 2026-08-20 4 Chief Legal Officer acquired 21,284 shares (grant or award)
  • 2026-08-20 4 Chief Medical Officer acquired 22,807 shares (grant or award)
  • 2026-08-20 4 Co-Chief Executive Officer acquired 60,039 shares (grant or award)
  • 2026-08-20 424B5 Prospectus
  • 2026-08-18 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d180581d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…